American Parkinson Disease Association’s Research Grants support scientists studying Parkinson’s causes, biology, and treatment, from basic science to rehabilitation, to advance insights toward a cure.
Funder: American Parkinson Disease Association
Due Dates: April 9, 2027 (LOI opens) | May 17, 2027 (LOI due) | June 21, 2027 (Full application invitations) | July 19, 2027 (Full application due) | October 2027 (Decisions) | January 1, 2028 (Award begins)
Funding Amounts: Up to $100,000 for one year
Summary: Supports U.S.-based scientists developing new insights into the causes, biology, and treatment of Parkinson’s disease.
Key Information: Applicants must be research scientists with an MD, MD/PhD, or PhD; newcomers to Parkinson’s research receive favorable consideration.
The American Parkinson Disease Association (APDA) Research Grants support projects developing new insights into the pathophysiology, etiology, and treatment of Parkinson’s disease. Research may span the pipeline from basic science to rehabilitation-focused projects. The program aims to bring new investigators into Parkinson’s research while supporting important new ideas, and APDA will consider all innovative ideas.
Applicants may also select the special topic “Molecular Mechanisms of Environmental Toxicity in PD.” This topic focuses on novel mechanisms of Parkinson’s-related neurotoxicity and common pathways of neurodegeneration caused by environmental risks for the disease. The program forms part of APDA’s research mission to discover the causes of Parkinson’s disease and find a cure.